Jeannie Hou

Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

Paul B. Chapman, Axel Hauschild, Caroline Robert et al. · New England Journal of Medicine · 2011 · 7.7K citations · Full text

Medicine, Molecular Genetics, Oncology +9

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

Aleksandar Sekulić, Michael R. Migden, Nicole Basset‐Séguin et al. · BMC Cancer · 2017 · 412 citations · Full text

Medicine, Oncology, Pharmacology +14

Regulation of the Human hsp70 Promoter by p53

S. Nicholas Agoff, Jeannie Hou, Daniel I. H. Linzer et al. · Science · 1993 · 296 citations

Life Sciences, Genetics, Molecular Biology +17

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

John V. Heymach, Bruce E. Johnson, Diane Prager et al. · Journal of Clinical Oncology · 2007 · 292 citations

Medicine, Oncology, Pharmacology +15

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC

Aleksandar Sekulić, Michael R. Migden, Karl D. Lewis et al. · Journal of the American Academy of Dermatology · 2015 · 209 citations · Full text

Medicine, Dermatology, Oncology +8